Tranexamic acid has been used for many years to minimise blood loss during surgery and, more recently, to reduce morbidity after malor trauma. While small studies have confirmed reduction in blood loss during tonsillectomy with its use, the rate of primary haemorrhage following tonsillectomy has not been reported. In the UK, less than 50% of children having a tonsillectomy are managed as day cases, partly because of concerns about bleeding during the inilia 24 hours following su rge ry.
paediatric tonsillectomy PJ Robb, G Thorning Epsom ancl St Helier Unir-ersity Hospitals \HS Tfust, UK Tranexamic acid has been used for many years to minimise blood loss during surgery and, more recently, to reduce morbidity after malor trauma. While small studies have confirmed reduction in blood loss during tonsillectomy with its use, the rate of primary haemorrhage following tonsillectomy has not been reported. In the UK, less than 50% of children having a tonsillectomy are managed as day cases, partly because of concerns about bleeding during the inilia 24 hours following su rge ry.
A retrospective review of clinical records between January 2OO7 and January 2013 produced 476 children between the ages of 3 and 16 years who underwent CoblationrM tonsillectomy, with or without adenoidectomy and/or insertion of ventilation tubes. All children were ASA (American Society of Anesthesiologists) grade 7 or 2 and anaesthetised using a standard day surgery protocol. Following induction of anaesthesia, all received intravenous tranexamic acid at a dose of 10-15mg/kg. Two children (0.4%) had minor bleeding within two hours of surgery. Both returned to theatre for haemostasis and were discharged home later the same day with no further compiications. The expected rate for primary haemorrhage in the UK using this technique for tonsillectomy is 1%.
Perioperative tranexamic acid in a single, parenteral dose might reduce the incidence of primary haemorrhage following paediatric tonsillectomy, facilitating discharge on the day of surgery. The results from this observational study indicate a potential benefit and need for a large, prospective, multicentre, randomised controlled trial. Ti'aneramic acid (TX.\) has been araiiable frtr overl,0 ,rears but has onl) reccntl] lteeu cstaltlishetl as a raluable phartnaceutical tool lirr rerlucing ltlood loss during stu'ger1 anrl follorling majol trarmta.lr U'ltile a clinical irrrlicat-ion for T,L{ is prerention and redr-rction of bleeding aller tonsillectornl',r the dmg has not achieved u-idespread. I'outilre use.
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TXA is a slnthetic lvsiue analogtre, proclucing an antifibrinolr-tic ell'ect b1, tlte reversiltle ltlockade of lvsine binditrg sites on plasntinogen rnolecules. This inhiltits the corn-ersion of plasrninogen to pltrsmin on tht' surlace ol the fitrrin.a The rlmg has been triclelt. used pal'etlterallr in cardiac. orthopaedic ancl urological slu'gel'). to rechrce perioperatire bloocl loss.i In orthopaeclic srrrgery-. TX{ has lteen shonn to lessen bloocl loss during linee ar.throplasty b1 50'lu, reducing the need lor transfusion lith no increaserl risk of tlrromboemltolic cornplications.o It has also lteen tuserl topicalh as a ntouthl-ash lollouing clental anri olal surgert.' TXA has lteen rellorted as part of the rnanagernent of patients undergoing aclc.nol-onsillectonr\, uith inherited bleeding disorders.s'e T\A apptiecl topicalll'as a gel during tonsillectomy shorred no benelit over placebo in rerlucing haemorrhage follon,ing tonsille<'ton'r1-. 10 \lininrising postoperatite blecding on the clay of surgery ujth 'l'.\A rnal'facilittrtc a lise in the rate ol arnltulatory cale (dav-case) tolsillectonrt. itr the LK. The objective of the study rvas to assess r,rhether TXA rvoulcl minimise ur abolish the primarl' haernorrhage on the day' of surgel1,, facilitating discharge ]rorne the satne day. Secondarl haemorrhage \ras not assessed irt this sturll:. In the LK. TXA is routinell' available onl-v in tablet fomr, nnsuitable for paerliatlic adrninistration. The short half-life of TXA rnearls that no effect on seconclarl' haemor- The sarne sLrrgeon operatecl on aII the chilclren, usir-rg Coblationl\r dissection ancl haernostasis fol' the tonsillectoml' and suction cliathetml. lbr the adenoidectoml.l+ hr all cases, the bloorl Ioss 'r\-as nol nreasured but it u'as clinicalll negligible. rvith suabs larell' r'equired for haernostasis.
The chilrlren 'rrere itnaesthetised using an adapted version of a prer-iouslv published da,_v-case anaesthetic plotocol.li The protocol rras rnoclifiecl to substitute intravenous paracetarnol at lSrng/kg for rectal paracetarnol. Perioperative slow intravenous infusion of TXA at 10-15mg,/lig rvas aclrninistered.
Postoperativell-, the children \\-ere observed for a rninimurn of sir hours with nreasurernent of pulse antl respiration rates according to a standard nurse-lecl protocol. Anl evidence ol bleeding, eithel' bv a change in obsen-ations or u,ith lresh blood fronr the nose ol mouth, h'iggerecl immediate rel-ielr. by a doctor. There l.ere no significant aclverse efl'eds fi'on-r the aclministration of the TXA. T\.ro of the chiklren (0.a%) in the stucly erperienced a single episode of postoperative vonriting but rvithout ericlence ol bleeding. T\r o chilclren (0.4%) developed minimal bleeding uithin the first trro postoperative hours.
(Our routine [ranagement is to retum to t]reatre an]-child producing fresh blood from the rnouth or nose during the imrnediate postoperative period of obsen'ation on the rvatcl.) Both patients had rninor bleecling points treated under general anaesthesia nsing Coblatior-rr\r. Both rere dischargetl home the same da1., sir hours after the second procedure. \o child de'r.el oped bl eedin g follor,rirrg an aclenoidectoml-.
All children rvere clischarged home on the da_v of surgery There lvere no readmissions uith reactionarl' bleeding during the 24 hours following surger)-.
In this observational pilot str,rd1, the outcomes rvere benchrnarli.ed relative to the LIK National Prospective Tonsillectomy Auclit (\PTA).ltJ This inclurlerl 21,065 chilclren uncler the age of 16 years undergoing a tonsillectom-l-. Only 12% were discharged home on the daJ' of the operation as arnbulator-v care patiellts. Bleeding accottnterl for 22'k of delavecl dischalges. (During the atrdit, Coblatiottr\I l as associated u'ith a higher postoperative bleeding rate thatl other techniques.) Thc 0.4% primarl' haetnorrirage rate in our stucll ol' nearll' 500 children cornpares \'\ell $ith the NPTA, tvhiclt reported a l7o prinrarl ltaemorrhage ratc fbllolrirtg Cobla-tionr\I tonsillectorn)-for 1.565 patients.ro Llsing this as a compalison group, the tlata frour ottr stttcll' are too small to produce statistical significance lrith chi-squarecl test anallsis. Thel' do, horvever, inclicate a potential ltenelicial outconle frorn the use of proph-vlaclic TXA during tonsillectonr). surger)'. both to reduce bleeding on tIIe clal of surgerl ancl to inclease the rate of discharge frorn hospital ott the da1-of operation.
A ntuuber of stuclies have published lariable results on bleeding after tonsillectotrl using different tlpes of antifibrinoll-tics. One shorved no sigtrificant ltenefit frorthe routine use ol TXA during tonsillectoml'r7 u'hile others have confirmed significant rerluction iu blood loss duriug stlrgerJ using conventional clissection tecl'uriques."'1e Itt a further randourisecl controlled trial (RCT), a single dose of intratenor-rs, perioperative TXA at l0rng,/kg producecl a rnean bklori loss of 56.6.1,m1 cornpared lith 66.52tnl itr tl're coutrol glonp.ro The ar-rthors reportecl no acllerse effet:ts lrorn TXA. Three patients (5%) developed prirnary haernot'ttage ltut none ol these required operative inten'ention. d s1'stematic revien' antl rneta-anal-v-sis of the use olTXA for tonsillectorn-y confimred TXA rech-rcecl blood loss cluring sul'ger]' but failecl to dernonstrate auy recluction in the rate of haemorrhage follouing tonsillecton't1:.'' The authols noted that ol the 58 citations fouttcl iu au extettsite literature search. onlv 7 coLrld be included in their final anall'sis. These studies valiecl enormouslf in the age range, dosage, scheclule anrl duration of T\A adrninistration, incltrcling one papel reporting topical application of a TXA paste, resulting in a higher bleecling rate than the placebo group.l'
The srnall number of studies included in this meta-analysisll rvas so heterogerleous tllat it is cli|icult to draurneaningful conclnsions regarcling the applicability. of TXA in reducing postoperati\-e bleeding after tonsillectoml'. A helpful conclnsion is the safet--v of TXA, *-ith onl-v I of the for conrplications fbllou.ing tonsille ctornr,. \\'hile oLrr patients u.ere all \SA gratlt, 1 or 9. the \PTA did not stratifv children into AS,.l glarles. Iftruer-er. the proportion of chiklren lrar.ing an electir,e tolsillectontl n'ho arc .\S{ grade 5 or,1, is nrinirtral. The nnnrlters in our.stud)'\lere stnall llut a po\\er anahsis indicates a stu(lt population of thousantls lould be needecl to rlelivel statistical signifliirtrnce. Our studv u-as restrictecl to pritnarl. haenrollhage to considel' the lteuelits of rlar,-case discharge aiter tousillt'ctornv anc[ because no suitaltlt, paedjatric preparation ol oriil TX{ is culrentlv a\.ailable in the trlr.. I'his stucly reports a single surgeon experielce, using only Coblationr\I for tonsillectonty and suction coagulatiotr lor arlcnoitlectomr,. \\,-hile tlle cotnparatite data front the \PTA u,ere fol the sante tonsillectonl) technique. it is uncertain rvhat ellect the T\A had olel atrd altove thal of the surgeon's erperieuce and the tet.luriclues rrsed.
Our pilot stucl5 strpports the concllrsious ol a ureta-anal-Isis pulllished in 2011r1 that an atlcquatell' pol.erccl, prospeclive, RCT is neede(l to assess the potential benelit oI' T\A in the reduction ol prilnat')'Itaernorrhnge afler tonsillectoml.. \ lalge, rnulticentre, prospcctir'e. RCT could also aclllrinister n suitable oral TXA prepar.atiotl frtr ten dal,s follovring sru'ger)' to assess anv I'eduction in seconrlarl, haemorrhage. *:rZr:tn=:=--=.,,
